Skip to main navigation Skip to search Skip to main content

Developing a Mass Spectrometry Based Assay to Monitor Protease Activity in Plasma to Predict a Patient’s Response to Cancer Treatment.

  • David Potier
  • , John R. Griffiths
  • , Michael J. Walker
  • , Richard D. Unwin
  • , Duncan Smith
  • , Yvonne Connolly
  • , Ralf Hoffmann
  • , Anthony D. Whetton

Research output: Chapter in Book/Conference proceedingConference contributionpeer-review

Original languageEnglish
Title of host publicationhost publication
Publication statusPublished - Jul 2012
EventRoyal Society of Chemistry Analytical Research Forum - Durham, UK
Duration: 2 Jul 20124 Jul 2012

Conference

ConferenceRoyal Society of Chemistry Analytical Research Forum
CityDurham, UK
Period2/07/124/07/12

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this